This opportunity is no longer accepting applications.
grant RFA-DA-23-008

Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)

The increase in stimulant use among opioid users since 2016 complicates the opioid epidemic, exacerbated by the ongoing spread of fentanyl. Users of both stimulants and opioids present new challenges to healthcare providers, often showing less motivation to address their stimulant use. Stimulant use, especially substances like meth, cocaine, and ketamine, significantly contributes to HIV cases…

Stimulant use has been increasing among opioid users since 2016, based on overdose data and this makes control of the opioid epidemic more difficult, as it occurs in addition to the continuing influx of fentanyl and related compounds. Stimulant/opioid users present unfamiliar clinical issues to …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Awards & funding

Award Ceiling: $400,000
Award Amount: $400,000

Dates

Opportunity Released: May 16, 2022
Open for Submission: May 16, 2022
Submission Deadline: November 12, 2024
Application Window Closes: November 12, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.